Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation (Q53269437)
scientific article published on 21 June 2014
Language:
Current Data About Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation
(P31) (Q13442814)
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

(P50) (Q53134138)
(P1545) 1
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

(Q51775643)
(P1545) 7
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

(Q37621431)
(P1545) 12
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

(Q123943285)
(P1545) 10
(P1932) Bernard Park
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

(Q64210897)
(P1545) 5
(P1932) Sandra P D'Angelo
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

(P304) 405-410
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

(P407) (Q1860)

(P433) 6
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

(P478) 15
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

(P577) Saturday, June 21, 2014
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

(P921) (Q356033)
(P887)

(P1433) (Q332299)
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

(P1476) "Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation" (language: en)
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

(P2093) Anya Litvak
(P1545) 2
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

Maria E Arcila
(P1545) 3
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

Payal Patel
(P1545) 4
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

Lee M Krug
(P1545) 6
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

Alicia Mattson
(P1545) 8
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

Claire Coeshott
(P1545) 9
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

David M Apelian
(P1545) 11
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

Christopher G Azzoli
(P1545) 13
(P248)
(P698) 25044103
(P813) Saturday, May 12, 2018
(P854) http://europepmc.org/abstract/MED/25044103

other details
description scientific article published on 21 June 2014

External Links
(P356) 10.1016/J.CLLC.2014.06.002
(P698) 25044103